Global Women's Health Market 2016-2020

  • ID: 3678095
  • Report
  • Region: Global
  • 65 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Agile Therapeutics
  • AstraZeneca
  • EffRx
  • Ligand Pharmaceuticals
  • Medicines 360
  • Novo Nordisk
  • MORE
About Women's Health Market

Women’s health refers to the overall well-being experienced by women - this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer).

It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments) or other socioeconomic issues.

The analysts forecast the global women's health market to grow at a CAGR of 3.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global women's health market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of drugs and devices for women's health issues.

The market is divided into the following segments based on geography:

- Americas
- APAC
- Europe
- MEA

The report, Global Women's Health Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

- Allergan
- Bayer HealthCare
- Merck
- Pfizer
- Teva Pharmaceuticals

Other prominent vendors

- Agile Therapeutics
- Amgen
- Apothecus Pharmaceutical
- AstraZeneca
- Blairex Laboratories
- Bristol-Myers Squibb
- EffRx
- Ferring International Center
- GlaxoSmithKline
- HLL Lifecare
- Janssen Pharmaceutical
- Lipocine
- Ligand Pharmaceuticals
- Lupin Pharmaceuticals
- Mayer Laboratories
- Medicines 360
- Neurocrine Biosciences
- Novartis
- Novo Nordisk
- Pantarhei Bioscience
- Sanofi

Market drivers

- Rise in number of older women worldwide

Market challenges

- High cost and inaccessibility of health services

Market trends

- Rise in STIs

Key questions answered in this report:

- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agile Therapeutics
  • AstraZeneca
  • EffRx
  • Ligand Pharmaceuticals
  • Medicines 360
  • Novo Nordisk
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by application
  • Market overview
  • Global postmenopausal osteoporosis market
  • Global contraceptives market
  • Global infertility market
  • Global menopause market
  • Global endometriosis market
  • Global polycystic ovary syndrome market
PART 07: Geographical segmentation
  • Market overview
  • Women's health market in Americas
  • Women's health market in Europe
  • Women's health market in APAC
  • Women's health market in MEA
PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • Allergan
  • Bayer HealthCare
  • Merck
  • Pfizer
  • Teva Pharmaceuticals
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits

Exhibit 01: Global women's health market segmentation
Exhibit 02: Product offerings
Exhibit 03: Global women's health market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global women's health market segmentation by application 2015
Exhibit 06: Global women's health market segmentation by application 2020
Exhibit 07: Global women's health market by application 2015-2020 ($ billions)
Exhibit 08: Global women's health market by application 2015-2020 (% share)
Exhibit 09: Global postmenopausal osteoporosis market 2015-2020 ($ billions)
Exhibit 10: Global contraceptives market 2015-2020 ($ billions)
Exhibit 11: Global infertility market 2015-2020 ($ billions)
Exhibit 12: Global menopause market 2015-2020 ($ billions)
Exhibit 13: Global endometriosis market 2015-2020 ($ billions)
Exhibit 14: Global polycystic ovary syndrome market 2015-2020 ($ millions)
Exhibit 15: Global women's health market geographical segmentation 2015
Exhibit 16: Global women's health market geographical segmentation 2015-2020 ($ billions)
Exhibit 17: Women's health market in Americas 2015-2020 ($ billions)
Exhibit 18: Women's health market in Europe 2015-2020 ($ billions)
Exhibit 19: Women's health market in APAC 2015-2020 ($ billions)
Exhibit 20: Women's health market in MEA 2015-2020 ($ billions)
Exhibit 21: Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Companies focusing on women’s health
Exhibit 25: Allergan: Key takeaways
Exhibit 26: Bayer HealthCare: Key takeaways
Exhibit 27: Merck: Key takeaways
Exhibit 28: Pfizer: Key takeaways
Exhibit 29: Teva Pharmaceuticals: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Agile Therapeutics
  • AstraZeneca
  • EffRx
  • Ligand Pharmaceuticals
  • Medicines 360
  • Novo Nordisk
  • MORE
New Report Released: – Global Women's Health Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Women's Health Market: Allergan, Bayer HealthCare, Merck, Pfizer, and Teva Pharmaceuticals.

Other Prominent Vendors in the market are: Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, and Sanofi.

Commenting on the report, an analyst from the research team said: “The limited funding for public health clinics globally has led to a rise in common STIs such as chlamydia, syphilis, and gonorrhea. Such diseases should be treated urgently as they can cause pelvic inflammatory diseases, stillbirths, neonatal infections, and infertility. Various public health institutes highly recommend that women who are sexually active must undergo STI screening once a year. The increase in detections of STIs will positively affect this market.”

According to the report, the rise in the number of older women worldwide has spurred the market, with companies investing in R&D to develop new women's health solutions to enhance their existing portfolio. Many of the diseases women are diagnosed with are associated with old age. This will fuel the growth of the women's health market over the forecast period.

Further, the report states that one of the major issues faced by women is the cost of treatment and the inaccessibility of therapies to treat diseases, especially in developing and under-developing countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Allergan
- Bayer HealthCare
- Merck
- Pfizer
- Teva Pharmaceuticals
- Agile Therapeutics
- Amgen
- Apothecus Pharmaceutical
- AstraZeneca
- Blairex Laboratories
- Bristol-Myers Squibb
- EffRx
- Ferring International Center
- GlaxoSmithKline
- HLL Lifecare
- Janssen Pharmaceutical
- Lipocine
- Ligand Pharmaceuticals
- Lupin Pharmaceuticals
- Mayer Laboratories
- Medicines 360
- Neurocrine Biosciences
- Novartis
- Novo Nordisk
- Pantarhei Bioscience
- Sanofi
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll